The Professor Thomas Borody Interview: the Ivermectin-Based Tri-Therapy for COVID-19
Play • 24 min
While having developed a therapy for COVID-19, Doctor Borody is most famous for his ground-breaking work developing the triple therapy cure for peptic ulcers in 1971.

In Australia alone, this therapy is estimated to have saved hundreds of thousands of lives, and the health system more than $10 billion in medical care and operations.

Doctor Borody founded the Centre for Digestive Diseases (CDD) in 1984 after a distinguished career with leading hospitals including St Vincent’s in Sydney and the Mayo Clinic in the USA.

He is a world-renowned leader in the clinical microbiota field dating back to 1988.

Doctor Borody holds over 180 patents in areas such as; treatment of Helicobacter pylori & Crohn’s disease.

This interview was conducted on September 10 2020 and concisely covers a range of issues associated with COVID-19 therapies, including:

- What is Dr. Borody's recommended ivermectin-based tri-therapy
- How is this early therapy administered to old and younger people alike
- Examples of elderly people “turning the corner” after being treated
- The problems with randomized controlled trials
- The ethics of those trials and how they are not appropriate for COVID-19
- A message to other countries when it comes to the necessity to treat this disease early.

More information and the video version of this interview can be found at:
More episodes
Clear search
Close search
Google apps
Main menu